Open Access

[Retracted] EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer

  • Authors:
    • Lei Wu
    • Tianyi Wang
    • Dongning He
    • Xiaoxi Li
    • Youhong Jiang
  • View Affiliations

  • Published online on: October 9, 2023     https://doi.org/10.3892/mmr.2023.13112
  • Article Number: 225
  • Copyright : © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

December-2023
Volume 28 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu L, Wang T, He D, Li X and Jiang Y: [Retracted] EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer. Mol Med Rep 28: 225, 2023
APA
Wu, L., Wang, T., He, D., Li, X., & Jiang, Y. (2023). [Retracted] EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer. Molecular Medicine Reports, 28, 225. https://doi.org/10.3892/mmr.2023.13112
MLA
Wu, L., Wang, T., He, D., Li, X., Jiang, Y."[Retracted] EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer". Molecular Medicine Reports 28.6 (2023): 225.
Chicago
Wu, L., Wang, T., He, D., Li, X., Jiang, Y."[Retracted] EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer". Molecular Medicine Reports 28, no. 6 (2023): 225. https://doi.org/10.3892/mmr.2023.13112